Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Artesian Therapeutics Inc.

www.artesianrx.com

Latest From Artesian Therapeutics Inc.

Deal Watch: Shire, Allergan Move To Shore Up Core Franchises

Bristol acquires Cardioxyl and its Phase II congestive heart failure candidate as the latest deal to firm up its specialty drug pipeline, while Sanofi inks a cancer immunotherapy deal with BioNTech and a pair of diabetes-related partnerships with Hanmi and Lexicon.

BioPharmaceutical Deals

Selected Start-Ups (12/02)

In Vivo briefly summarizes the technologies of these recently founded companies: Artesian Therapeutics Inc., Dynogen Pharmaceuticals Inc., GeneCraft Inc., MRI Cardiac Services Inc., Threshold Pharmaceuticals Inc. and ZuChem Inc.

See All

Company Information

UsernamePublicRestriction

Register